4Accepted Aug 31, 8:00 PM ET
UTI Director Robert DeVincenzi Buys 1,000 Shares
Accepted (ET)
8:00 PM
Aug 31, 2026
Filed
Aug 31, 2026
Documents
1
Size
5.1 KB
Summary
UTI Director Robert DeVincenzi Buys 1,000 Shares
What Happened
Robert Thomas DeVincenzi, a director of Universal Technical Institute (UTI), bought 1,000 shares of UTI common stock in open-market transactions on August 27, 2026. The reported weighted-average price was $21.80 per share, for a total transaction value of approximately $21,800. This was a purchase (acquisition) rather than a sale.
Key Details
- Transaction date: 2026-08-27 (reported on Form 4 filed 2026-08-31). Filing appears to be within the required two business days.
- Transaction type: Open-market purchase (Code P).
- Shares acquired: 1,000 shares at a weighted-average price of $21.80; total ≈ $21,800.
- Price range: Purchases occurred in multiple trades at prices between $21.75 and $21.85 (footnote indicates a weighted average and that the filer can provide per-trade breakdown on request).
- Shares owned after transaction: Not disclosed in the provided filing summary.
- Footnote: F1 explains the reported price is a weighted average across multiple trades and that detailed per-price share counts are available upon request.
Context
Open-market purchases by directors are closely watched by investors because they show a director acquiring company stock, but such transactions are factual signals — not proof of future performance. This filing reports a modest-sized purchase by a director and appears to have been filed timely.